Recent advances in antibody‐based immunotherapy strategies for COVID‐19
A Esmaeilzadeh, S Rostami… - Journal of cellular …, 2021 - Wiley Online Library
The emergence of a new acute respiratory syndrome Coronavirus 2 (SARS‐CoV‐2), the
cause of the 2019‐nCOV disease (COVID‐19), has caused a pandemic and a global health …
cause of the 2019‐nCOV disease (COVID‐19), has caused a pandemic and a global health …
COVID-19 management landscape: a need for an affordable platform to manufacture safe and efficacious biotherapeutics and prophylactics for the developing …
To gain world-wide control over COVID-19 pandemic, it is necessary to have affordable and
accessible vaccine and monoclonal antibody technologies across the globe. In comparison …
accessible vaccine and monoclonal antibody technologies across the globe. In comparison …
Ação bactericida de isoaglutininas ABO em diferentes diluições de anticorpos anti-ABO
NM Gomes, AB Cruz, D Valcarenghi… - … de Biotecnologia & …, 2021 - revista.ueg.br
Tendo em vista o grande polimorfismo dos sistemas de grupos sanguíneos e que uma das
hipóteses para explicá-los seja a co-evolução com patógenos, esta pesquisa teve como …
hipóteses para explicá-los seja a co-evolução com patógenos, esta pesquisa teve como …
The Concept of Repurposing in COVID-19 Infection
L Potey, AC Dudhe, D Tumme, R Dudhea… - Coronaviruses, 2022 - ingentaconnect.com
The strategy of drug repurposing has been proved successful in response to the current
coronavirus pandemic, with remdesivir becoming the first drug of choice, an antiviral drug …
coronavirus pandemic, with remdesivir becoming the first drug of choice, an antiviral drug …
[PDF][PDF] Developing Preventive, Curative and Recovery (PCR) Strategy for Managing COVID-19
The re-occurring waves of COVID-19 pandemic has taken so many lives all over the world.
Some country has managed it very well whereas some is still struggling to manage it. Along …
Some country has managed it very well whereas some is still struggling to manage it. Along …